MedTwenty

Technology Intelligence

Precision Medicine

MedTwenty Technology Score 84

Therapeutics

Biomarker-directed therapeutics, companion diagnostics and gene-based interventions.

Market size$96bn (2026)
Growth12% CAGR to 2030
Funding (12m)$5.6bn raised in the last twelve months
Quarterly change+12% q/q

Timeline

  1. Sep 2026Casgevy label extended to children aged two and over.

Segment forecasts and vendor benchmarks

Professional membership unlocks five-year segment forecasts, contracted-volume benchmarks and comparison across the full technology universe.

Upgrade